🔥🐔 BizChicken 🐔🔥
Learn About the Corporations Around You
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Galera Therapeutics, Inc.
Market Cap: Lowest
Employees: Lowest
avasopasem manganese (GC4419)
Galera Therapeutics, Inc. is a clinical stage biopharmaceutical company focusing on developing and commercializing therapeutics aimed at transforming radiotherapy in cancer. Their lead product candidate, avasopasem manganese, has completed a Phase III clinical trial targeting oral mucositis in head and neck cancer patients.
Symbol: GRTX
Recent Price: $0.03
Industry: Biotechnology
CEO: Dr. J. Mel Sorensen M.D.
Sector: Healthcare
Employees: 7
Address: 2 West Liberty Boulevard, Malvern, PA 19355
Phone: 610 725 1500
Leadership
- J. Mel Sorensen, MD, President and Chief Executive Officer
- Lawrence Alleva, Chair of the Board of Directors
- Emmett Cunningham, MD, PhD, Board Member
- Kevin Lokay, MS, Board Member
- Michael Powell, PhD, Chair of the Nominating and Corporate Governance Committee
- Linda West, Chair of the Compensation Committee
Last updated: 2024-12-31